HK1039792B - 用於神經細胞轉移基因的負鏈rna病毒載體 - Google Patents

用於神經細胞轉移基因的負鏈rna病毒載體

Info

Publication number
HK1039792B
HK1039792B HK02101038.0A HK02101038A HK1039792B HK 1039792 B HK1039792 B HK 1039792B HK 02101038 A HK02101038 A HK 02101038A HK 1039792 B HK1039792 B HK 1039792B
Authority
HK
Hong Kong
Prior art keywords
negative
rna virus
sense rna
vetor
nerve cell
Prior art date
Application number
HK02101038.0A
Other languages
English (en)
Other versions
HK1039792A1 (en
Inventor
福村正之
淺川誠
長谷川護
Original Assignee
株式會社載體研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式會社載體研究所 filed Critical 株式會社載體研究所
Publication of HK1039792A1 publication Critical patent/HK1039792A1/xx
Publication of HK1039792B publication Critical patent/HK1039792B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031Beta-glucuronidase (3.2.1.31)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18811Sendai virus
    • C12N2760/18841Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18811Sendai virus
    • C12N2760/18871Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK02101038.0A 1998-07-03 2002-02-09 用於神經細胞轉移基因的負鏈rna病毒載體 HK1039792B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20433398 1998-07-03
PCT/JP1999/003552 WO2000001837A1 (fr) 1998-07-03 1999-07-01 Vecteur de virus a arn a brin negatif

Publications (2)

Publication Number Publication Date
HK1039792A1 HK1039792A1 (en) 2002-05-10
HK1039792B true HK1039792B (zh) 2006-08-18

Family

ID=16488770

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101038.0A HK1039792B (zh) 1998-07-03 2002-02-09 用於神經細胞轉移基因的負鏈rna病毒載體

Country Status (12)

Country Link
US (1) US20050158279A1 (zh)
EP (1) EP1094115B1 (zh)
JP (1) JP3883213B2 (zh)
KR (1) KR20010074631A (zh)
CN (1) CN1249248C (zh)
AT (1) ATE430806T1 (zh)
AU (1) AU4395599A (zh)
CA (1) CA2336472C (zh)
DE (1) DE69940848D1 (zh)
ES (1) ES2326101T3 (zh)
HK (1) HK1039792B (zh)
WO (1) WO2000001837A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4791651B2 (ja) * 2000-05-18 2011-10-12 株式会社ディナベック研究所 外来遺伝子導入用パラミクソウイルスベクター
WO2002000264A1 (fr) * 2000-06-27 2002-01-03 Dnavec Research Inc. Vecteur de virus pour transfert de gene dans des cellules renales
CN1929867A (zh) 2004-01-13 2007-03-14 株式会社载体研究所 肿瘤的基因治疗,即利用编码免疫刺激性细胞因子的单链负链rna病毒载体进行的治疗

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US5824655A (en) * 1995-02-15 1998-10-20 The University Of Utah Anti-transforming growth factor-β gene therapy
DK0864645T3 (da) * 1995-10-31 2005-10-24 Dnavec Research Inc Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
KR100525687B1 (ko) * 1995-11-01 2005-11-25 가부시끼가이샤 디나벡 겡뀨쇼 재조합체 센다이바이러스
CA2325564A1 (en) * 1998-03-27 1999-10-07 Cytos Biotechnology Ag Inducible alphaviral gene expression system
WO1999066061A1 (fr) * 1998-06-18 1999-12-23 Dnavec Research, Inc. Phage de transfert d'acide nucleique
US6451579B1 (en) * 1998-07-29 2002-09-17 Invitrogen Corporation Regulated expression of recombinant proteins using RNA viruses
US6723938B1 (en) * 1999-03-22 2004-04-20 Peter Jon Gates Electrostatic conductive induction separator
DE60035589T2 (de) * 1999-05-18 2008-04-17 Dnavec Research Inc., Tsukuba Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen
AU2002224113A1 (en) * 2000-11-27 2002-06-03 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and utilization thereof

Also Published As

Publication number Publication date
CN1249248C (zh) 2006-04-05
HK1039792A1 (en) 2002-05-10
EP1094115B1 (en) 2009-05-06
CN1314949A (zh) 2001-09-26
US20050158279A1 (en) 2005-07-21
JP3883213B2 (ja) 2007-02-21
DE69940848D1 (de) 2009-06-18
CA2336472C (en) 2010-08-31
EP1094115A4 (en) 2005-11-02
ES2326101T3 (es) 2009-09-30
KR20010074631A (ko) 2001-08-04
AU4395599A (en) 2000-01-24
CA2336472A1 (en) 2000-01-13
ATE430806T1 (de) 2009-05-15
WO2000001837A1 (fr) 2000-01-13
EP1094115A1 (en) 2001-04-25

Similar Documents

Publication Publication Date Title
HK1244504A1 (zh) 反義設計
ATE289630T1 (de) Transfer von mrnas unter verwendung von polykationischen verbindungen
HK1047129A1 (en) Sequence-specific dna recombination in eukaryotic cells
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
PT832264E (pt) Plasmideo para a transferencia de acidos nucleicos a celulas e metodos de utilizacao.
FI970983A (fi) Molekyylien siirto solujen sytoplasmaan
ZA954451B (en) The cytoplasmic inhibition of gene expression
WO1999036511A3 (en) Feline immunodeficiency virus gene therapy vectors
HUP9700429A3 (en) Nucleic acid constructs for the cell cycleregulated expression of genes, cells containing such constructs and their use for preparing drugs
ZA978536B (en) Nucleic acid constructs containing hybrid promoters for use in gene therapy.
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
WO2004044164A3 (en) Method for identifying risk of melanoma and treatments thereof
WO2000063397A3 (en) Methods for delivering inhibitory rna to plants and applications thereof
CA2358040A1 (en) Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
IL131014A0 (en) Methods for cultivating cells and propagating viruses
HK1039792A1 (en) Negative-sense rna virus vetor for nerve cell
AU5206899A (en) Uses of dna-pk
AU2294102A (en) Mutant muscle-specific enhancers
IL148595A0 (en) Novel cell cycle checkpoint genes and proteins encoded thereby
EP1134285A4 (en) NUCLEIC ACID FRAGMENT, RECOMBINANT VECTOR CONTAINING THIS FRAGMENT AND MEDIATED METHOD FOR SUPPORTING THE EXPRESSION OF A STRUCTURAL GENE
WO2001090391A3 (en) Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
ZA971086B (en) New thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy.
EP1832663A3 (en) Uses of DNA-PK
AU7771100A (en) Development of an effective gene transfer technique for introducing foreign dna into sperm cells

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110701